| 1 |
33707771 | Striatal ΔFosB gene suppression inhibits the development of abnormal involuntary movements induced by L-Dopa in rats. | 2021 Dec |
2 |
| 2 |
32387398 | Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats. | 2020 Aug |
2 |
| 3 |
30645726 | Differential Expression of Striatal ΔFosB mRNA and FosB mRNA After Different Levodopa Treatment Regimens in a Rat Model of Parkinson's Disease. | 2019 Apr |
12 |
| 4 |
29968767 | Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats. | 2018 Jul 3 |
2 |
| 5 |
28256089 | Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease. | 2017 Apr |
1 |
| 6 |
25146322 | Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia. | 2016 Mar 1 |
7 |
| 7 |
25442003 | Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia. | 2016 Mar 1 |
2 |
| 8 |
26997328 | Inhibition of Glycogen Synthase Kinase-3β (GSK-3β) as potent therapeutic strategy to ameliorates L-dopa-induced dyskinesia in 6-OHDA parkinsonian rats. | 2016 Mar 21 |
1 |
| 9 |
25196732 | Effects of prolonged neuronal nitric oxide synthase inhibition on the development and expression of L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. | 2015 Feb |
1 |
| 10 |
25787808 | Effect of simvastatin on L-DOPA-induced abnormal involuntary movements of hemiparkinsonian rats. | 2015 Aug |
1 |
| 11 |
25896846 | Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. | 2015 Apr 21 |
1 |
| 12 |
23428503 | Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/deltaFosB expression. | 2013 Apr 29 |
1 |
| 13 |
21129389 | BN82451 attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. | 2011 Mar |
2 |
| 14 |
21507338 | Differential expression of FosB, c-Fos, and Zif268 in forebrain regions after acute or chronic L-DOPA treatment in a rat model of Parkinson's disease. | 2011 Jun 1 |
3 |
| 15 |
20505100 | Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements. | 2010 May 26 |
3 |
| 16 |
18952677 | Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. | 2008 Dec |
1 |
| 17 |
17055656 | Expression pattern of JunD after acute or chronic L-DOPA treatment: comparison with deltaFosB. | 2007 Jan 5 |
1 |
| 18 |
17329435 | High-frequency stimulation of the subthalamic nucleus potentiates L-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease. | 2007 Feb 28 |
2 |
| 19 |
15056471 | Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy). | 2004 Apr |
2 |
| 20 |
12373525 | Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. | 2002 |
1 |
| 21 |
11683909 | Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease. | 2001 Oct |
3 |
| 22 |
10579213 | Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment. | 1999 |
8 |
| 23 |
10600402 | Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. | 1999 Dec |
3 |